1. Home
  2. NRXP vs PODC Comparison

NRXP vs PODC Comparison

Compare NRXP & PODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • PODC
  • Stock Information
  • Founded
  • NRXP 2015
  • PODC 2013
  • Country
  • NRXP United States
  • PODC United States
  • Employees
  • NRXP N/A
  • PODC N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • PODC
  • Sector
  • NRXP Health Care
  • PODC
  • Exchange
  • NRXP Nasdaq
  • PODC Nasdaq
  • Market Cap
  • NRXP 58.5M
  • PODC 47.8M
  • IPO Year
  • NRXP N/A
  • PODC N/A
  • Fundamental
  • Price
  • NRXP $3.58
  • PODC $1.65
  • Analyst Decision
  • NRXP Strong Buy
  • PODC
  • Analyst Count
  • NRXP 5
  • PODC 0
  • Target Price
  • NRXP $31.40
  • PODC N/A
  • AVG Volume (30 Days)
  • NRXP 416.8K
  • PODC 34.4K
  • Earning Date
  • NRXP 11-13-2025
  • PODC 11-06-2025
  • Dividend Yield
  • NRXP N/A
  • PODC N/A
  • EPS Growth
  • NRXP N/A
  • PODC N/A
  • EPS
  • NRXP N/A
  • PODC N/A
  • Revenue
  • NRXP N/A
  • PODC $53,954,000.00
  • Revenue This Year
  • NRXP N/A
  • PODC $17.91
  • Revenue Next Year
  • NRXP $395.09
  • PODC $14.41
  • P/E Ratio
  • NRXP N/A
  • PODC N/A
  • Revenue Growth
  • NRXP N/A
  • PODC 17.74
  • 52 Week Low
  • NRXP $1.10
  • PODC $1.10
  • 52 Week High
  • NRXP $6.01
  • PODC $2.94
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 67.97
  • PODC 46.64
  • Support Level
  • NRXP $3.19
  • PODC $1.51
  • Resistance Level
  • NRXP $3.84
  • PODC $1.80
  • Average True Range (ATR)
  • NRXP 0.22
  • PODC 0.11
  • MACD
  • NRXP 0.05
  • PODC -0.01
  • Stochastic Oscillator
  • NRXP 70.87
  • PODC 32.79

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About PODC PodcastOne Inc.

PodcastOne Inc is a podcast platform and publisher that makes its content available to audiences via all podcasting distribution platforms, including its website, its PodcastOne app, Apple Podcasts, Spotify, Amazon Music, and more.

Share on Social Networks: